Acute Porphyria Drugs

Monograph

J01DB01 - Cefalexin
Propably not porphyrinogenic
PNP

Rationale
Not metabolised. No data pointing to CYP interaction.
Chemical description
Perorally used cephalosporin (500 mg x 2) antibiotic used in uncomplicated urinary tract infections, skin and soft tissue infections and in pharyngotonsillitis where penicillin V has shown to be without effect. No data pointing to CYP-interaction. Excreted in unchanged form by the kidneys. South African list: use with caution. Australian list: unsafe, conflicting evidence. Drug Consult: safe.
IPNet drug reports
Uneventful use reported in 8 patients with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes J01D / J01DB or go back.
References
Tradenames

Keforal Keforal Cefalexina · Kefloridina Forte · Torlasporin Cefalexin · Pyassan Ceporex · Keforal Cefalexina · Keflex Cefalexin · Ceporex · Keflex Keflex Keflex Cefaleksyna Keforal Keflex Kefalex · Kefexin · Xefal Cefaleksin · Cefalexin · Palitrex Cefaleksin · Ceporex · Keflex · Oracef
In cooperation with IpNet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙